An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with numerous of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Worries
However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.
Some experts said the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has removed problematic material and banned associated hashtags and query recommendations. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.
Online Marketplace Activities
Research also discovered communities with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, glowing reviews and detailed guides for mixing or administering at home.
Within minutes of joining one community, a seller shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show black plastic parcels with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram said it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly serious medical dangers”.
